Serina Therapeutics (NYSEAMERICAN:SER) Insider Randall Moreadith Sells 6,500 Shares of Stock

Serina Therapeutics, Inc. (NYSEAMERICAN:SER) insider Randall Moreadith sold 6,500 shares of the company’s stock in a transaction on Monday, February 2nd. The stock was sold at an average price of $3.03, for a total transaction of $19,695.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.

Randall Moreadith also recently made the following trade(s):

• On Wednesday, January 28th, Randall Moreadith sold 6,500 shares of Serina Therapeutics stock. The shares were sold at an average price of $3.57, for a total value of $23,205.00.
• On Thursday, January 22nd, Randall Moreadith sold 2,500 shares of Serina Therapeutics stock. The stock was sold at an average price of $2.95, for a total value of $7,375.00.
• On Wednesday, January 21st, Randall Moreadith sold 2,000 shares of Serina Therapeutics stock. The shares were sold at an average price of $3.00, for a total value of $6,000.00.

Serina Therapeutics Trading Up 1.5%

SER opened at $2.76 on Wednesday. Serina Therapeutics, Inc. has a twelve month low of $1.71 and a twelve month high of $7.92.

About Serina Therapeutics

Serina Therapeutics, Inc, a biotechnology company, develops drugs to treat neurological diseases and pain. Its lead product candidate is SER 252, a POZ conjugate for the treatment of Parkinson’s disease. The company also develops SER 227 for long-acting pain relief; SER 214 to treat Parkinson’s disease; and SER 228 for the treatment of epilepsy. In addition, it develops POZ technology in lipid nanoparticle delivered ribonucleic acid vaccines for infectious diseases. Serina Therapeutics, Inc was founded in 2006 and is based in Huntsville, Alabama.